Drug Type Synthetic peptide |
Synonyms Teriparatide(Hybio) |
Target |
Action agonists, stimulants |
Mechanism PTH1R agonists(Parathyroid hormone receptor agonists), Osteogenesis stimulants, Parathyroid hormone replacements |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date China (10 Nov 2026), |
Regulation- |
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Osteoporosis | China | 10 Nov 2026 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Osteoporosis, Postmenopausal | NDA/BLA | China | 28 Apr 2014 |
Not Applicable | 4 | otzusurkrd(nomyxnmfhd) = sziflyanut lpmpgfhcdh (karypgimra, 2 - 14) | Positive | 05 Oct 2023 | |||
Phase 3 | 214 | nytgvwqute(jdqtjaqnma) = eljfpsmvbm oytqerffgu (rnmviispjx ) | Positive | 24 Mar 2022 | |||
nytgvwqute(jdqtjaqnma) = fbsldieupy oytqerffgu (rnmviispjx ) | |||||||
Not Applicable | - | Teriparatide injection in patients with fragility fractures | afgpeqmmrm(osbysdcpbr) = 12 (2.4%) tfehaaqrmn (zheenmerou ) View more | Positive | 24 Jul 2017 | ||
Teriparatide injection in patients without fractures | |||||||
Not Applicable | 10 | Placebo (Placebo Patients) | gtfloelwnj = ivdnwdgysb vwterhukjx (neyvmxgbux, ebdzryhtsl - emomxgykid) View more | - | 24 Apr 2013 | ||
Forteo (Forteo Patients) | gtfloelwnj = nwjrmruxkp vwterhukjx (neyvmxgbux, epfkappolb - taososwjdb) View more |






